Oxidative stress and its association with cardiovascular disease in chronic renal failure patients

Indian Journal of Nephrology

Volumn 21, Issue 1, 2011, Pages 21-25

  Hambali, Z ^a   Ahmad, Z ^a,b   Arab, S ^a   Khazaai, H ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Institute of Bioscience   (Malaysia)

Author keywords

Chronic renal failure; CVD; oxidative stress

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEART INFARCTION; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDIALYSIS; PREVALENCE; WAIST CIRCUMFERENCE;

EID: 79953800803     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.75218     Document Type: Article

References (27)

1. Locatelli F, Bommer J, London GM, Martín-Malo A, Wanner C, Yaqoob M, et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant 2005;16:459-68.
2. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003;14:1927-39. (Pubitemid 36750489)
3. Mandal KA, Woodi M, Sood V, Krishnaswamy RP, Rao A, Ballal S, et al. Quantitation and characterization of glutathionyl haemoglobin as an oxidative stress marker in chronic renal failure by mass spectrometry. Clin Biochem 2007;40:986-94. (Pubitemid 47301798)
4. Brunini TM, Mendes-Ribeiro AC, Ellory JC, Mann GE. Platelet nitric oxide synthesis in uremia and malnutrition: A role for L-arginine supplementation in vascular protection? Cardiovasc Res 2007;73:359-67. (Pubitemid 44937696)
5. Ronco C, Brendolan A, Levin NW. Cardiovascular Disorders in Hemodialysis. 14th International Course on Hemodialysis, Vicenza, May 2005.
6. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142.
7. Annuk M, Zilmer M, Lind L, Linde T, Fellström B. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001;12:2747-52. (Pubitemid 33115422)
8. Hemmelgarn BR, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Walsh M, et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007;18:993-9. (Pubitemid 46434517)
9. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002;39:135-9.
10. Levey AS, Coresh J, Bolton K. Disease outcome quality initiative. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification. Kidney Am J Kidney Dis 2002;39:S1-266.
11. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2002;24:469-73.
12. Sasikala M, Sadasivudu B, Subramanyam C. A putative role for calcineurin in lymphopenia associated with chronic renal failure. Clin Biochem 2000;33:691-4. (Pubitemid 32146206)
13. Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004;44:381.
14. Shoji T, Ishimura E, Inaba M, Tabata T, Nishizawa Y. Atherogenic lipoproteins in end-stage renal disease. Am J Kidney Dis 2001;38:S30-3. (Pubitemid 32927608)
15. Clermont G, Lecour S, Lahet J, Siohan P. Alteration in plasma antioxidant Capacities in chronic renal failure and haemodialysis patients. Cardiovasc Res 2000;47:618-23.
16. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004;24:1246-52. (Pubitemid 38880016)
17. Wong JR, Wu. Endothelial dysfunction and chronic kidney disease: treatment options. Curr Opin Investig Drugs 2008;9:970-82.
18. Cross J. Endothelial dysfunction in uraemia. Blood Purif 2002;20:459-61. (Pubitemid 35007561)
19. Matsuoka H. Endothelial dysfunction associated with oxidative stress in human. Diabetes Res and Clin Practice 2001;54:S65-72. (Pubitemid 33081108)
20. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8. (Pubitemid 33108132)
21. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997;51:1678-95. (Pubitemid 27252735)
22. Wilcoc JN, Subramanian RR, Tracey WR, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic. Arterioscler Thromb Vasc Biol 1997;17:2479-88. (Pubitemid 28015984)
23. van Guldener C, Nanayakkara PW, Stehouwer CD. Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. Clin Chem Lab Med 2007;45:1683-7. (Pubitemid 350232968)
24. Vaziri ND, Zhenmin NI, Wang XQ, Oveisi F, Zhou XJ. Down regulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 1998;274:F642-9.
25. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, et al. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 1998;52:171-81.
26. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:998-1005. (Pubitemid 38737823)
27. Yan Z, Hansson GK. Over expression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 1998;8:21-9. (Pubitemid 28074015)